Kudo T, Abe I, Minezaki M, Sugimoto K, Fujii H, Ohishi H, Nakagawa M, Yano S, Matsubayashi S, Fukudome M, et al. Investigation of metabolic and circulatory parameters that predict effects of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, on blood glucose and body weight in a retrospective, multicenter study. J Diabetes Metab. 2018. 9. 11. 810-810
